While a number of IPOs have been pulled or delayed in 2026, the biotech sector has bucked the trend, with 26 companies debuting in U.S. markets.
Anthropic is about to go public. Here are the proxies that could benefit
Stocks with exposure to the AI company could win as traders buzz over the hot new IPO.
MSG just spun off the Knicks and Rangers. How one analyst sees them trading
The spinout will probably unlock value in MSG Rangers and MSG Knickerbockers, according to Guggenheim Securities.
Robinhood to rally on prediction markets and new offerings, Bernstein says
Robinhood Markets is poised to see considerable upside due to its deepening push into crypto and prediction markets, among other offerings, per Bernstein.
This hospice services stock is outperforming the S&P 500. Jefferies sees more gains ahead
The investment bank upgraded the medical and plumbing services stock to buy from hold.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 posted back-to-back gains on Tuesday as tech shares rose.
Robinhood quarterly revenue rises 12% as event contracts, options offset crypto slump
Robinhood’s third-quarter revenue met expectations, fueled by the company’s expansion into options, predictions markets and other financial services.
How investors can position ahead of into the Fed’s next policy decision
The Federal Reserve’s October rate decision has been a focus for investors and economists as Chairman Kevin Warsh has rejected traditional forward guidance.
AI debt fears ease ahead of Oracle, Alphabet and Amazon updates. Here’s what to watch.
Credit markets will be closely watching updates from Oracle and other hyperscalers later this week. What to expect.
AI stocks have rattled U.S. and emerging markets. Japan and Europe could help investors diversify
Turbulence in the tech sector underscores the importance of a more diversified portfolio.